Conjugated Estrogens Tablets
Product Details:
-
Grade
USP (United States Pharmacopeia)
-
Application
Taken orally for the treatment of symptoms associated with menopause and prevention of osteoporosis.
-
Molecular Formula
C18H24O2 (for the primary compound Estrone in conjugated estrogens)
-
CAS No
472-61-307 (for the primary compounds in conjugated estrogens)
-
Purity
Pharmaceutical Grade
-
Formulations Type
Pharmaceutical
-
Formulations Form
Tablets
-
Click to View more
-
Conjugated Estrogens Tablets Product Specifications
-
Pharmaceutical Grade
-
472-61-307 (for the primary compounds in conjugated estrogens)
-
Varies based on packaging commonly available in 0.3 mg 0.45 mg 0.625 mg 0.9 mg or 1.25 mg dosages per tablet.
-
C18H24O2 (for the primary compound Estrone in conjugated estrogens)
-
Tablets
-
Adult Women
-
Hormone Replacement Therapy Menopause Symptom Management
-
Pharmaceutical
-
USP (United States Pharmacopeia)
-
Store at room temperature between 20-25C (68-77F) away from light and moisture. Keep out of reach of children.
-
Follow the prescription provided by a licensed healthcare provider. Typically once daily with or without food.
-
Taken orally for the treatment of symptoms associated with menopause and prevention of osteoporosis.
|